Literature DB >> 11206448

Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.

W Pendergast1, B R Yerxa, J G Douglass, S R Shaver, R W Dougherty, C C Redick, I F Sims, J L Rideout.   

Abstract

A series of dinucleoside 5-polyphosphates UpnU (n = 2-7) was synthesized. Their relative potencies as agonists at the G-protein-coupled receptors P2Y1, P2Y2, P2Y4, and P2Y6 were determined by intracellular calcium measurements using fluorescent imaging techniques. The correlation of phosphate chain length to activities at these receptors is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11206448     DOI: 10.1016/s0960-894x(00)00612-0

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  31 in total

Review 1.  Molecular recognition at purine and pyrimidine nucleotide (P2) receptors.

Authors:  Kenneth A Jacobson; Stefano Costanzi; Michihiro Ohno; Bhalchandra V Joshi; Pedro Besada; Bin Xu; Susanna Tchilibon
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

2.  Studies of Mg2+/Ca2+ complexes of naturally occurring dinucleotides: potentiometric titrations, NMR, and molecular dynamics.

Authors:  Noa Stern; Dan Thomas Major; Hugo Emilio Gottlieb; Daniel Weizman; Alon Haim Sayer; Eliav Blum; Bilha Fischer
Journal:  J Biol Inorg Chem       Date:  2012-05-18       Impact factor: 3.358

3.  Structure-activity relationships of uridine 5'-diphosphate analogues at the human P2Y6 receptor.

Authors:  Pedro Besada; Dae Hong Shin; Stefano Costanzi; Hyojin Ko; Christophe Mathé; Julien Gagneron; Gilles Gosselin; Savitri Maddileti; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2006-09-07       Impact factor: 7.446

Review 4.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

5.  Endothelium-dependent relaxation evoked by ATP and UTP in the aorta of P2Y2-deficient mice.

Authors:  Pieter-Jan D F Guns; Tim Van Assche; Paul Fransen; Bernard Robaye; Jean-Marie Boeynaems; Hidde Bult
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

6.  Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.

Authors:  Hak Sung Kim; R Gnana Ravi; Victor E Marquez; Savitri Maddileti; Anna-Karin Wihlborg; David Erlinge; Malin Malmsjö; José L Boyer; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2002-01-03       Impact factor: 7.446

Review 7.  P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential.

Authors:  Gary A Weisman; Lucas T Woods; Laurie Erb; Cheikh I Seye
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-09       Impact factor: 4.388

8.  Alarmones as Vestiges of a Bygone RNA World.

Authors:  Ricardo Hernández-Morales; Arturo Becerra; Antonio Lazcano
Journal:  J Mol Evol       Date:  2019-01-02       Impact factor: 2.395

9.  Ligand binding to a remote site thermodynamically corrects the F508del mutation in the human cystic fibrosis transmembrane conductance regulator.

Authors:  Chi Wang; Andrei A Aleksandrov; Zhengrong Yang; Farhad Forouhar; Elizabeth A Proctor; Pradeep Kota; Jianli An; Anna Kaplan; Netaly Khazanov; Grégory Boël; Brent R Stockwell; Hanoch Senderowitz; Nikolay V Dokholyan; John R Riordan; Christie G Brouillette; John F Hunt
Journal:  J Biol Chem       Date:  2018-06-14       Impact factor: 5.157

10.  Expression of the P2Y₂ receptor on the rat ocular surface during a 1-year rearing period.

Authors:  Hidetoshi Tanioka; Yumi Kuriki; Asuka Sakamoto; Osamu Katsuta; Kouichi Kawazu; Masatsugu Nakamura
Journal:  Jpn J Ophthalmol       Date:  2014-09-02       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.